
Pairing chemoembolization with radiofrequency ablation improved survival in patients with unresectable hepatocellular cancer, according to a multidisciplinary group based at Shangdong University in Jinan, China. Their study results demonstrated how tumor microarchitecture could be manipulated to boost localized therapy.










